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INTRODUCTION 
Malaria should be considered as a serious disease since it 
accounts for the death of around 3 million people every 
year. This disease remains as a major public health issue 
in our country due to slow progress in its control. 
Malaria is a disease caused by the parasites called 
‘Plasmodia’ that lives part of its life in humans and part 
in mosquitoes.
1
 
Around 1.5 million cases of malaria are being reported 
annually by the National Vector Borne Disease Control 
Programme (NVBDCP), of which 50% are due to 
P.falciparum.
2 
Dakshina Kannada, a coastal district located on the 
western coast of Karnataka state was relatively free from 
malaria until early 1990 with only few cases. But since 
1990, various industrial projects and other construction 
activities began with poor little care on hygienic aspects 
on due course there was an outbreak of malaria. It has 
been identified that the incidence of malaria increases 
with the onset of monsoon (June to October), as the 
water logging favors mosquito breeding and thus end up 
in transmission of the disease
3
. 
Many states inhabited by ethnic tribes mainly in the 
forest ecosystems, malaria exist with the preponderance 
of P.falciparum
4
. 
The greatest task is with the resistance of drug occurring 
with P.falciparum. It is necessary to take the guidance of 
the principles of clinical management o f  malaria which 
include early recognition of infection due to P.falciparum 
and rapid management procedures. This in turn helps the 
physicians in easy overcome on complicated situations. 
The main objective of the study was to understand the 
prescribing patterns and to compare it with the existing 
national guidelines for the management of malaria 
MATERIALS AND METHODS 
The study was conducted at K.S Hegde Charitable 
Hospital. It is a 750-beded private tertiary care hospital 
centrally located in Dakshina Kannada, Mangalore. 
It is a retrospective cross-sectional study in which subjects 
admitted with a primary diagnosis of malaria during the 
one year period from June 2010 to May 2011 to study the 
clinical symptoms and the prescribing pattern of anti-
malarial drugs. 
All patients above 15 years of age diagnosed to have 
malaria (after doing a peripheral blood smear) were 
included in the study.  The study protocol was approved 
by the institutional human ethics committee. 
The collected data includes 
 Patient demographic details 
 Presenting signs and symptoms 
 Clinical diagnosis and co-morbidities 
 Previous exposure to malaria 
 Laboratory tests and Parasitological examinations 
 Drug treatment regimens  
RESULTS AND DISCUSSION 
Demographics 
In our study we have analyzed, 117 cases of confirmed 
malaria, admitted and treated in the hospital. Out of these, 
ABSTRACT 
The study was a retrospective prescription analysis of evaluation of prescription patterns on patients admitted with malaria. 
The study was conducted for a one year period from June 2010 to May 2011. The study aimed to compare the prescriptions 
with the existing treatment guidelines. Evaluation of data was done for various parameters which include patient 
demographics, presenting signs and symptoms, previous exposure to malaria, co-morbidities, initial laboratory results, 
parasitological examinations during hospitalization and drug treatment regimens. A total of 117 prescriptions were analyzed. 
Among the various anti-malarial drugs given alone, Primaquine was the most prescribed anti-malarial drug (20.4%), followed 
by Chloroquine (7.2%), Artesunate (3.8%), and Arteether (1.3%), irrespective of the type of therapy. Chloroquine with 
Doxycycline (10%), Artesunate with Doxycycline (8.2%), Artesunate with Sulphadoxine/Pyrimethamine (12%) were 
considered to be appropriate rational combination regimens. It was found that 78.7% of these cases have been treated in 
accordance with the WHO norms and 21.3% of cases not in accordance with the norms. Inappropriate combinations which 
accounts of (20.7%) and an inappropriate choice of anti-malarial of (0.6%) were observed in the study.   The study concluded 
that there is a need of individual treatment protocol for malaria caused by different parasites and regular training programs for 
the prescribers for the better patient care as the study site is observed as malaria zone.  
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there were 95 (81.2%) males and 22 (18.8%) female 
patients. The age of the patients ranged from 15 years to 
73 years. Majority of the people n=88 (75.2%) belong to 
the age group of 25-45 years. Though the ages of the 
subjects were different, malaria parasitaemia did not vary 
significantly between different age groups. 
Seasonal variation 
The cases of malaria admitted and treated during 
different seasonal variations in a calendar year, were 
studied and are mentioned in Table 1. The highest 
frequency of cases was observed during the months of 
November and December (24%), and with the lowest rate 
of infection during the month of January (2.6%). A study 
conducted by Bonnlander et al at Central Haiti’s 
Schweitzer hospital reported to have the peak case 
incidence occurred during November to January, a few 
months after the rainy season.
5 
 
Table 1: Seasonal variation of malaria cases per month 
Month No. of Malaria cases Percentage 
June 12 10.3 
July 11 9.4 
August 13 11.1 
September 5 4.3 
October 9 7.7 
November 16 13.7 
December 12 10.3 
January 3 2.6 
Februrary 9 7.7 
March 7 6.0 
April 9 7.7 
May 11 9.4 
 
Distribution of Plasmodium Species 
A detailed distribution on the type of Plasmodium species 
among the diseased individuals is mentioned in Table 2. 
There were 83 (70.9%) cases of P.vivax infection, 18 
(15.4%) cases of P.falciparum and 16 (13.7%) cases of 
mixed infection (P.vivax plus P.falciparum).. In a 
retrospective analysis conducted by Muddaiah et al in 
south canara found that P.vivax was the major parasite type 
(52.54%), followed by P.falciparum (33.75%) 
6
. Highest 
number of P.vivax infections recorded in the present 
study shows their higher transmission rate in this region. 
An epidemiological study conducted in Qatar also revealed 
that P.vivax is the most common cause of imported malaria, 
with the majority acquired from the Indian subcontinent
7
. 
Table 2: Types of malaria parasites 
Parameter Frequency Percentage 
P. falciparum 18 15.4 
P. vivax 83 70.9 
Mixed infections 16 13.7 
Total 117 100 
 
Past medical history 
Only 16 patients had the past medical history of malaria. 
Three of the patients showed relapse because of 
discontinuing treatment. 
Clinical symptoms of malaria  
The initial clinical features and other findings are 
summarized in Table 3. Fever was the most commonly 
presented symptom by the patients and it accounted for all 
the cases  (100%).  This  was  followed  by  other  major  
symptoms  such  as  chills   (89.7%), headache (57.3%), 
vomiting (49.6%), abdominal pain (23.1%), myalgia 
(21.4%), sweats (5.1%).  
Table 3: Symptoms presented at the hospital by the 
patient 
Clinical presentation Frequeny Percentage 
Fever 117 100 
Chills 105 89.7 
Headache 67 57.3 
Vomiting 58 49.6 
Abdominal pain 28 23.9 
Myalgia 25 21.4 
Splenomegaly 11 9.4 
Hepatomegaly 9 7.7 
Sweats 6 5.1 
 
Comparison of symptoms according to plasmodia 
species 
We have compared the presenting symptoms and clinical 
findings according to the  parasite species. Abdominal 
symptoms including abdominal pain - 9 (50%); vomiting -
13 (72.2%); hepatomegaly - 4 (22.2%) dominated in 
P.falciparum infection. The ‘p’ value on comparison with 
P.vivax for abdominal pain, vomiting and hepatomegaly in 
P.falciparum infection was 0.0242, 0.0487 and 0.0236 
respectively and found the statistically significant 
difference. The details are depicted in Table 4 . A 
study based on the clinical features of malaria in Pakistan 
revealed that vomiting and abdominal pain occurred  more  
frequently  in  patients  infected  with  P.falciparum  than  
any  other parasites
8
. 
Frequency of anti-malarial usage in various 
plasmodium species 
Comparisons of drugs used among patients with malaria 
according to Plasmodium species was mentioned in Table 
5. In case of P.falciparum, the most commonly prescribed 
antimalarial was Artesunate 16 (88.9%), followed by 
Chloroquine 8 (44.4%) and Primaquine 8 (44.4%). For 
P.vivax, the most commonly administered drug  was  
Chloroquine  61  (73.5%)  followed  by  Primaquine  56  
(67.5%)  and Artesunate 19 (22.9%), and in case of mixed 
infections, the most commonly prescribed drug was 
Artesunate 13 (81.3) followed by Primaquine 10 (62.5%) 
and Chloroquine 8 (50.0%). 
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Table 4: Comparison of presenting signs and symptoms among cases of malaria according to Plasmodium species 
Clinical 
Presentation 
P.falciparum 
(N=18) % 
P.vivax 
(N=83) % 
 
OR 
 
95% CI 
 
P Value 
Fever 100.0 100.0 0.22 0.004 –11.53 0.4548 
Headache 55.6 56.6 0.96 0.34 – 2.67 0.9338 
Abdominal Pain 50.0 22.9 3.37 1.97 – 9.69 0.0242* 
Chills 94.4 92.8 1.32 0.15 – 11.73 0.8005 
Sweats 5.6 3.6 1.57 0.15 – 16.01 0.7041 
Myalgia 27.8 21.7 1.39 0.44 – 4.41 0.5775 
Vomiting 72.2 45.8 3.10 1.01 – 9.42 0.0487* 
Hepatomegaly 22.2 4.8 5.64 1.27 – 25.24 0.0236* 
Splenomegaly 11.1 7.2 1.60 0.31 – 8.68 0.5833 
P<0.05* 
Table 5:  Frequency of use  of different  anti-malarials in various species of malaria infection 
Drugs 
Species 
P.falciparum     n (%) P.vivax      n (%) Mixed infection     n (%) 
Chloroquine 8 (44.4) 61 (73.5) 8 (50.0) 
Artesunate 16 (88.9) 19 (22.9) 13 (81.3) 
Sulphadoxine/Pyrimethaine 4 (22.2) 14 (16.9) 4 (25.0) 
Primaquine 8 (44.4) 56 (67.5) 10 (62.5) 
Doxycycline 8 (44.4) 18 (21.7) 6 (37.5) 
Quinine 2 (11.1) - 1 (6.3) 
Artemether 2 (11.1) - - 
Artemether-Lumefantrine 1 (5.6) 4 (4.8) - 
Arteether - 13 (15.7) 4 (25.0) 
 
Anti-malarial therapy based on WHO guidelines 
We have conducted a comparison study on the anti-
malarial drug prescribing pattern with the WHO. In 
single drug therapy, Primaquine was the most prescribed 
anti- malarial drug (20.4%), followed by Chloroquine 
(7.2%), Artesunate (3.8%), and Arteether (1.3%), 
irrespective of the type of therapy. In combined drug 
therapy Chloroquine with Doxycycline (10%), Artesunate 
with Doxycycline (8.2%), Artesunate with 
Sulphadoxine/Pyrimethamine (12%) were prescribed and 
considered as rational in accordance with WHO. Thus, 
78.7% of these cases have been treated in accordance 
with the WHO norms. The study result also shows the drug 
therapeutical management of the remaining 21.3% of cases 
was not according to the WHO norms. We have observed 
the inappropriate combinations in antimalarial drug 
therapy w h i c h  include (20.7%) and an inappropriate 
choice of anti-malarial drug at the rate of (0.6%) during the 
study (Table 6). A Similar study report also suggested that 
Chloroquine with Sulphadoxine/Pyrimethamine is not a 
suitable combination especially in first-line treatment of 
P.falciparum
9
.  A study by Abuaku B K et al found that 
inappropriate doses of chloroquine prescriptions were 
more in private than government health care systems
10
.   
Table 6: Anti-malarial mono and combination therapy based on WHO guidelines 
Correct anti-malarial mono and combination therapy (78.7%) 
Description Number (Frequency) Percentage (%) 
Chloroquine 23 7.2 
Artesunate 12 3.8 
Primaquine 65 20.4 
Arteether 4 1.3 
Artemether-Lumefantrine 4 1.3 
Chloroquine+Arteether 13 8.2 
Chloroquine + Doxycycline 16 10.0 
Primaquine+Artesunate 4 2.6 
Artesunate+ Sulphadoxine/Pyrimethamine 12 7.5 
Artesunate+Doxycyline 13 8.2 
Others 13 8.2 
Inappropriate combination or choice of anti-malarials (21.3%) 
Sulphadoxine/Pyrimethamine 2 0.6 
Chloroquine+Artesunate 17 10.7 
Chloroquine+ Sulphadoxine/Pyrimethamine 16 10.0 
Total 100 
 
Joel et al                                           Journal of Drug Delivery & Therapeutics; 2013, 3(4), 89-92 92 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
CONCLUSION 
Malaria is a significant and serious public health problem 
in Karnataka state and particularly in Dakshina Kannada 
district. Our study has defined the characteristics of 
malaria cases admitted to K S Hedge Charitable Hospital 
in Mangalore. The age group of 15 to 45 years is mostly 
affected, which includes a high number of male adults. 
Seasonal trend showed occurrence of cases mainly during 
early rainfall [May-August; n=47, 40.17%] and a late 
peak during November-December [n=28, 24%]. Majority 
of the cases were infected by P.vivax. Fever was 
present in all cases; abdominal symptoms dominate in 
P.falciparum infection when compared with P.vivax 
infection. 
Chloroquine was the most commonly prescribed 
antimalarial drug during this study period.  Due  to  
raising  fear  of  resistance,  multidrug  approach  has  been  
tried  in majority of cases and thereby helped in 
preventing resistance and serious complications. We have 
observed that 78.7% of these cases have been given 
treatment according to WHO guidelines and the remaining 
did not.  
There is a need for special treatment protocol for malarial 
based on the different plasmodium species and for drug 
resistant malaria in this particular locality. It is suggested 
that adequate vector control measures associated with 
active surveillance will certainly reduce the malaria 
transmission in this region. Moreover, Implementation of 
regular training programs, workshops and other modes, to 
enhance the prescriprition patterns among prescribers 
should be encouraged for better patient care.  
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